Patents by Inventor Hayley Ann Reece

Hayley Ann Reece has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20230339880
    Abstract: The invention relates to crystalline forms of (6aR,10aR)-1-Hydroxy-6, 6-dimethyl-3-(2-methyl-2-octanyl)-6a,7,10,10a-tetrahydro-6H-benzo[c]chromene-9-carboxylic acid (ajulemic acid), including pharmaceutical compositions comprising a crystalline form of ajulemic acid and methods of making a crystalline form of ajulemic acid. The invention also relates to the use of pharmaceutical compositions comprising a crystalline form of ajulemic acid for the treatment of disease, including inflammatory diseases and fibrotic diseases.
    Type: Application
    Filed: October 9, 2020
    Publication date: October 26, 2023
    Inventors: David Richard BOOTH, Chaoyi DENG, Robert Paul DISCORDIA, Feng GUO, Clifton David LEIGH, Kristos Adrian MOSHOS, Hayley Ann REECE, Abdolsamad TADAYON, Tingting XU, Hang ZHANG
  • Publication number: 20230271922
    Abstract: The present disclosure relates to crystalline forms of N-{3-[1-(2-nitrophenyl)-1H-pyrrol-2-yl]-allylidene}-aminoguanidinium salts having high solubility. The disclosure also relates to use of said crystalline forms in medicine.
    Type: Application
    Filed: August 23, 2022
    Publication date: August 31, 2023
    Inventors: Thomas BOESEN, Thomas Engelbrecht Nordkild JONASSEN, Hayley Ann REECE, Natalie Louise KELK, Alice Jane TURNER, Ross MCLELLAN
  • Publication number: 20230002319
    Abstract: The present disclosure relates to crystalline forms of N-{3-[1-(2-nitrophenyl)-1H-pyrrol-2-yl]-allylidene}-aminoguanidinium salts having high solubility. The disclosure also relates to use of said crystalline forms in medicine.
    Type: Application
    Filed: August 23, 2022
    Publication date: January 5, 2023
    Inventors: Thomas BOESEN, Thomas Engelbrecht Nordkild JONASSEN, Hayley Ann REECE, Natalie Louise KELK, Alice Jane TURNER, Ross MCLELLAN
  • Publication number: 20220356319
    Abstract: Sulcardine salts other than sulfuric acid salts of sulcardine, including crystalline sulcardine salts, are provided herein. Pharmaceutical compositions comprising such salts and methods of treating arrhythmias comprising administering effective amounts of such salts are also provided.
    Type: Application
    Filed: July 11, 2022
    Publication date: November 10, 2022
    Inventors: Suzanne J. ROMANO, Hayley Ann REECE, Joseph Edward Gordon BENSON, Sarah COLLINS, Gary T. ELLIOTT, Mireille GILLINGS, Robert GOODENOW, Curtis TYREE
  • Patent number: 11426382
    Abstract: Sulcardine salts other than sulfuric acid salts of sulcardine, including crystalline sulcardine salts, are provided herein. Pharmaceutical compositions comprising such salts and methods of treating arrhythmias comprising administering effective amounts of such salts are also provided.
    Type: Grant
    Filed: January 28, 2020
    Date of Patent: August 30, 2022
    Assignee: HUYABIO International, LLC
    Inventors: Suzanne J. Romano, Hayley Ann Reece, Joseph Edward Gordon Benson, Sarah Collins, Gary T. Elliott, Mireille Gillings, Robert Goodenow, Curtis Tyree
  • Patent number: 11020374
    Abstract: Sulcardine salts other than sulfuric acid salts of sulcardine, including crystalline sulcardine salts, are provided herein. Pharmaceutical compositions comprising such salts and methods of treating arrhythmias comprising administering effective amounts of such salts are also provided.
    Type: Grant
    Filed: October 23, 2020
    Date of Patent: June 1, 2021
    Assignee: HUYA Bioscience International, LLC
    Inventors: Suzanne J. Romano, Hayley Ann Reece, Joseph Edward Gordon Benson, Sarah Collins, Gary T. Elliott, Mireille Gillings, Robert Goodenow, Curtis Tyree
  • Publication number: 20210038568
    Abstract: Sulcardine salts other than sulfuric acid salts of sulcardine, including crystalline sulcardine salts, are provided herein. Pharmaceutical compositions comprising such salts and methods of treating arrhythmias comprising administering effective amounts of such salts are also provided.
    Type: Application
    Filed: October 23, 2020
    Publication date: February 11, 2021
    Inventors: Suzanne J. ROMANO, Hayley Ann REECE, Joseph Edward Gordon BENSON, Sarah COLLINS, Gary T. ELLIOTT, Mireille GILLINGS, Robert GOODENOW, Curtis TYREE
  • Publication number: 20200316024
    Abstract: Sulcardine salts other than sulfuric acid salts of sulcardine, including crystalline sulcardine salts, are provided herein. Pharmaceutical compositions comprising such salts and methods of treating arrhythmias comprising administering effective amounts of such salts are also provided.
    Type: Application
    Filed: January 28, 2020
    Publication date: October 8, 2020
    Inventors: Suzanne J. Romano, Hayley Ann Reece, Joseph Edward Gordon Benson, Sarah Collins, Gary T. Elliott, Mireille Gillings, Robert Goodenow, Curtis Tyree
  • Publication number: 20170174720
    Abstract: Disclosed herein are acid addition salts of cationic steroidal antimicrobials (“CSAs” or “ceragenins”) and methods of making the same. Particularly advantageous salt forms are identified, such as 1,5-naphthalenedisulfonic acid addition salts and sulfate addition salts. The acid addition salts may be formulated for treating subjects with ailments responsive to CSAs, including but not limited to treating bacterial infections. Accordingly, some embodiments include formulations and methods of administering acid addition salts of CSAs.
    Type: Application
    Filed: April 22, 2016
    Publication date: June 22, 2017
    Applicant: BRIGHAM YOUNG UNIVERSITY
    Inventors: Paul B. Savage, Saurabh Shashikant Chitre, Kunal Arvind Varia, Hayley Ann Reece, Thomas E. Jacks, Ross A. Miller, Jared Lynn Randall
  • Publication number: 20160311850
    Abstract: Disclosed herein are acid addition salts of cationic steroidal antimicrobials (“CSAs” or “ceragenins”) and methods of making the same. Particularly advantageous salt forms are identified, such as 1,5-naphthalenedisulfonic acid addition salts and sulfate addition salts. The acid addition salts may be formulated for treating subjects with ailments responsive to CSAs, including but not limited to treating bacterial infections. Accordingly, some embodiments include formulations and methods of administering acid addition salts of CSAs.
    Type: Application
    Filed: April 22, 2016
    Publication date: October 27, 2016
    Applicant: BRIGHAM YOUNG UNIVERSITY
    Inventors: Paul B. Savage, Saurabh Shashikant Chitre, Kunal Arvind Varia, Hayley Ann Reece, Thomas E. Jacks, Ross A. Miller, Jared Lynn Randall